Myasthenia gravis and also — anaesthetic mgmt for thymectomy for md anaesthesia exam . Short and crisp exam ready with subheadings and mnemonics to remember with possible viva questions .

Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Reading File
Finding Sources
I have sufficient material to write a thorough exam-ready answer. Let me now compile everything.

Myasthenia Gravis (MG) + Anaesthetic Management for Thymectomy

MD Anaesthesia Exam - Short & Crisp with Mnemonics + Viva Questions


PART 1 - MYASTHENIA GRAVIS

Definition

MG is an autoimmune postsynaptic neuromuscular junction (NMJ) disorder caused by IgG antibodies against nicotinic acetylcholine receptors (AChR) - leading to receptor destruction, complement-mediated end-plate damage, and fatigable skeletal muscle weakness.
Quick Mnemonic: "MG = Missing Gates" - the AChR "gates" at the NMJ are destroyed by autoantibodies.

Pathophysiology

  • IgG anti-AChR antibodies (found in 85-90% of generalized MG, 50-70% of ocular MG)
  • Anti-MuSK antibodies (muscle-specific tyrosine kinase) - in AChR-negative patients; more severe facial/bulbar involvement
  • Anti-LRP4 antibodies - 1-3%; milder disease
  • Thymoma present in 10-15% of MG patients; ~70% show thymic lymphoid follicular hyperplasia
  • Complement-mediated destruction of postsynaptic membrane → reduced functional AChRs
  • (Morgan & Mikhail's Clinical Anesthesiology, 7e, p.1181)

Clinical Features

Mnemonic: "PODS + R"
  • Ptosis (most common initial sign)
  • Ophthalmoplegia / diplopia
  • Dysphagia / Dysarthria (bulbar involvement)
  • Shortness of breath (respiratory muscles)
  • Rest improves, exertion worsens (pathognomonic fatigability)
Ocular MG only (no generalization) = 15-20% of patients.

MGFA Clinical Classification (Jaretzki Classification)

ClassDescription
IOcular only
IIaMild, limb/axial predominant
IIbMild, bulbar/respiratory predominant
IIIa/bModerate, limb or bulbar/respiratory
IVa/bSevere, limb or bulbar/respiratory
VRequires intubation ± ventilation
(Morgan & Mikhail's Clinical Anesthesiology, 7e)

Precipitants / Exacerbating Factors

Mnemonic: "MIST PEG"
  • Medications (aminoglycosides, fluoroquinolones, beta-blockers, Ca²+ channel blockers, lithium, chloroquine, neuromuscular blockers, magnesium)
  • Infection (most common precipitant)
  • Surgery / Stress
  • Thyroid disease (hyperthyroid worsens; hypothyroid also worsens and increases pyridostigmine need)
  • Pregnancy (unpredictable)
  • Electrophysiological / Emotional stress
  • General anaesthesia

Diagnosis

TestFinding
Edrophonium (Tensilon) testTransient improvement with short-acting anticholinesterase
Anti-AChR antibodiesConfirmatory in 85-90%
Repetitive nerve stimulation (RNS)Decremental response (>10%) at 3 Hz
Single-fibre EMG (SFEMG)Increased jitter - most sensitive test
CT chestThymoma screening (mandatory)
Ice pack testFor ocular MG - ptosis improves with cold

Myasthenic Crisis vs Cholinergic Crisis

FeatureMyasthenic CrisisCholinergic Crisis
CauseUndertreated MG / precipitantExcess anticholinesterase
WeaknessYesYes
PupilsNormal/dilatedMiotic (SLUDGE)
SecretionsMinimalExcessive
EdrophoniumImprovesWorsens
TreatmentIncrease anticholinesterase, IVIG, plasmapheresisStop anticholinesterase, atropine, ventilate
SLUDGE mnemonic for cholinergic crisis: Salivation, Lacrimation, Urination, Defecation, GI upset, Emesis

Treatment Summary

Mnemonic: "SIPS"
  • Symptomatic - Pyridostigmine (AChE inhibitor), 60 mg TDS-QID
  • Immunomodulation - IVIG, Plasma exchange (fastest acting, for crisis)
  • Pharmacological immunosuppression - Steroids, Azathioprine, Mycophenolate, Rituximab, Eculizumab
  • Surgical - Thymectomy (especially if thymoma; also beneficial in generalized MG without thymoma)

PART 2 - ANAESTHETIC MANAGEMENT FOR THYMECTOMY

Why Thymectomy?

  • Thymoma found in 10-15% of MG patients
  • 70% have thymic hyperplasia
  • Thymectomy leads to remission/improvement in MG in >50% of non-thymoma patients
  • Indications: Thymoma (mandatory), generalized MG (Class II-IV), age <60, AChR-antibody positive

Pre-operative Assessment

Mnemonic: "4 Rs"
  1. Respiratory function - FVC, FEV1 (FVC <2.9 L predicts need for postop ventilation)
  2. Regimen of medications - last dose of pyridostigmine, steroids
  3. Risk stratification - Osserman/MGFA class, bulbar involvement
  4. Review contraindicated drugs - aminoglycosides, Mg²+, succinylcholine carefully
Leventhal's Predictors of Post-op Ventilation (MGFA Score):
  • Duration of MG >6 years
  • History of COPD
  • Dose of pyridostigmine >750 mg/day
  • Vital capacity <2.9 L (Score ≥10 → likely to need post-op ventilation)
Pre-op optimization:
  • Pyridostigmine: continue or hold morning dose (institution-specific; many anaesthetists omit on day of surgery to reduce secretions and sensitivity to NMBDs)
  • Plasma exchange or IVIG if patient is in poor condition (Class III/IV)
  • Steroids: continue peri-operatively (stress dose if on long-term therapy)
  • Optimize pulmonary function

Anaesthetic Goals for Thymectomy

Mnemonic: "PLAN - V"
  • Prevent crisis (avoid precipitants: infection, stress, offending drugs)
  • Limit NMBDs (profound sensitivity to non-depolarizing agents)
  • Avoid respiratory depression (opioids and sedatives used carefully)
  • Neuromuscular monitoring (mandatory - TOF throughout)
  • Ventilation post-op planning

Premedication

  • Avoid benzodiazepines and opioids (respiratory depressants - use cautiously or avoid premedication)
  • Glycopyrrolate/Atropine: to manage excessive secretions if pyridostigmine is continued
  • Continue steroids
  • Antacid prophylaxis: metoclopramide + H2 blocker (risk of aspiration from bulbar MG)
  • Anti-anxiety: Small dose oral midazolam may be used cautiously with monitoring available

Induction

  • IV induction preferred: Propofol (drug of choice - attenuates airway reflexes, no epileptogenic effect, short duration)
  • Airway: Consider RSI if bulbar symptoms present (aspiration risk)
  • Succinylcholine: Avoid if possible - resistance to succinylcholine (need higher doses due to reduced AChRs); risk of phase II block unpredictable
    • If RSI absolutely needed: use high-dose succinylcholine (1.5-2 mg/kg) or prefer rocuronium 1.2 mg/kg + sugammadex reversal
  • Opioids: Short-acting agents preferred (remifentanil, fentanyl) - titrate carefully

Maintenance

Mnemonic: "No NMB if possible - TIVA/Volatile + TOF"
  • Volatile agents (sevoflurane, isoflurane, desflurane): Provide good muscle relaxation inherently; reduce NMBD requirement significantly
  • TIVA (Propofol + Remifentanil): Excellent option - avoids volatile-related muscle relaxation unpredictability
  • NMBDs:
    • If required: use short-/intermediate-acting non-depolarizing NMBDs (rocuronium, atracurium, mivacurium)
    • Dose: 1/10th to 1/4th of normal dose (profound sensitivity)
    • Mandatory TOF monitoring throughout
    • Avoid vecuronium/pancuronium (longer duration)
    • Prefer atracurium (organ-independent Hofmann elimination - safe in all patients)
  • Avoid long-acting NMBDs, aminoglycosides, magnesium, high-dose volatile agents without TOF monitoring

Surgical Approach

  • Sternotomy (median): traditional, good exposure, longer recovery
  • VATS (Video-Assisted Thoracoscopic Surgery): preferred now; less pain, faster recovery, less post-op ventilation need
  • Robotic: emerging
For VATS - one-lung ventilation (OLV) required:
  • Double-lumen tube (DLT) or bronchial blocker
  • MG patients tolerate OLV poorly if respiratory reserve is compromised - careful pre-op FVC assessment critical

Reversal and Extubation

Reversal:
  • Neostigmine: Use cautiously (anticholinesterase + glycopyrrolate). Risk: may precipitate cholinergic crisis + increase secretions
  • Sugammadex: Drug of choice for reversal if rocuronium used - reverses without cholinergic side effects, avoids interaction with MG medications
  • Confirm TOF ratio >0.9 before extubation
Extubation criteria:
  • TOF ratio >0.9
  • Sustained head lift >5 seconds
  • FVC >15 mL/kg
  • Spontaneous breathing, cooperative patient
  • Absence of bulbar symptoms / excess secretions
When to plan elective post-op ventilation:
  • Leventhal score ≥10
  • Class IV/V MG
  • Prolonged surgery
  • Intraoperative complications
  • Poor baseline FVC

Post-operative Management

  • ICU/HDU monitoring mandatory
  • Restart pyridostigmine via NG tube if extubated, or hold if ventilated (may increase secretions)
  • Watch for myasthenic crisis (most common 24-72 hrs post-op)
  • Analgesia: Avoid opioids if possible; use multimodal - paracetamol, NSAIDs, regional (thoracic epidural, paravertebral block excellent for sternotomy/VATS)
  • Physiotherapy and early mobilization

Drug Interactions Table - What to AVOID

Drug ClassExamplesEffect on MG
AminoglycosidesGentamicin, tobramycinBlock NMJ → worsen MG
FluoroquinolonesCiprofloxacinWorsen
Beta-blockersPropranololWorsen
Ca²+ channel blockersVerapamilWorsen
MagnesiumMgSO4Profound NMJ block
AntiarrhythmicsQuinidine, procainamideWorsen
Lithium-Worsen
Chloroquine-Worsen
Long-acting NMBDsPancuroniumProlonged block
OpioidsMorphineRespiratory depression

MG vs Lambert-Eaton (LES) - Classic Exam Comparison

FeatureMGLambert-Eaton (LES)
SitePost-synapticPre-synaptic
AntibodyAnti-AChRAnti-VGCC (voltage-gated Ca²+ channels)
MusclesOcular > Bulbar > LimbProximal limb > Ocular
AutonomicRareYes (dry mouth, constipation)
ReflexesNormalReduced but improve with exercise
RNSDecremental (3 Hz)Incremental (50 Hz)
WeaknessWorse with exertionImproves briefly with exertion
AssociationThymusSCLC (60%)
Sensitivity to NMBDs↑ to non-dep, resistance to dep↑↑ to both

POSSIBLE VIVA QUESTIONS

Q1. What is the mechanism of MG? A: IgG antibodies against nicotinic AChR at postsynaptic NMJ → receptor destruction + complement-mediated end-plate damage → fatigable weakness.
Q2. What is the MGFA Class V? A: Requires intubation with or without mechanical ventilation (except routine post-op management).
Q3. Why is succinylcholine avoided in MG? A: Reduced AChRs → resistance (need 1.5-2× dose). Risk of Phase II block. Unpredictable response. Preferred alternative is high-dose rocuronium + sugammadex.
Q4. What is your drug of choice for NMBD reversal in MG and why? A: Sugammadex - encapsulates rocuronium, no anticholinesterase activity, avoids cholinergic side effects and drug interactions with pyridostigmine.
Q5. What are Leventhal's predictors for post-operative ventilation? A: MG duration >6 years, COPD, pyridostigmine >750 mg/day, FVC <2.9 L. Score ≥10 predicts need for ventilation.
Q6. How do you differentiate myasthenic crisis from cholinergic crisis? A: Edrophonium test - improves in myasthenic crisis, worsens in cholinergic crisis. Clinical: SLUDGE features (miosis, secretions, bradycardia) in cholinergic crisis.
Q7. Why is atracurium preferred in MG patients requiring NMBDs? A: Hofmann elimination - organ-independent metabolism, predictable duration, not affected by anticholinesterase drugs.
Q8. What is the single-fibre EMG finding in MG? A: Increased jitter - most sensitive test for NMJ dysfunction.
Q9. What is OLV and how does it affect MG patients undergoing VATS thymectomy? A: One-lung ventilation required for VATS. MG patients with reduced FVC tolerate OLV poorly; double-lumen tube placed. Careful pre-op assessment of FVC and respiratory reserve is mandatory.
Q10. Which antibody predicts thymoma association in MG? A: Anti-AChR antibodies. Thymoma-related MG almost invariably has AChR antibodies (not anti-MuSK or LRP4). Additional antibodies against titin and ryanodine receptors are also common in thymoma-MG.
Q11. What is the role of TIVA in MG thymectomy? A: Propofol + remifentanil TIVA provides excellent conditions - avoids volatile-agent-induced NMJ effects, allows smooth titration, ideal for avoiding NMBDs altogether, and remifentanil's ultra-short action prevents respiratory depression at extubation.
Q12. Why is regional anaesthesia (thoracic epidural or paravertebral block) important in MG thymectomy? A: Reduces systemic opioid requirement → less respiratory depression → facilitates early extubation. Particularly valuable in sternotomy approach.

Sources: Morgan & Mikhail's Clinical Anesthesiology, 7e (p. 1180-1184); Bradley & Daroff's Neurology in Clinical Practice (blocks 3, 18, 23); Miller's Anesthesia, 10e; Adams & Victor's Principles of Neurology, 12e
This is a shared conversation. Sign in to Orris to start your own chat.